Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Lescarden Inc. (OTC BB:LCAR.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Recent Events
Aug 31Price hit new 52-week low ($0.07)
Location
420 Lexington Avenue, Suite 212
New York, NY 10170
Phone: (212) 687-1050
Fax: (212) 687-1051
Employees (last reported count): 3
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 54%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Lescarden, Inc. is engaged in the research, testing and development of medications for the control and cure of various diseases and the licensing of its technologies for commercialization by other companies. The Company's product developments continue to concentrate on its proprietary materials, Catrix and POLY-NAG, both in terms of their therapeutic, cosmetic and food supplement values. The Company is focusing a significant portion of its resources on the development of a complete marketing program for pure Catrix powder, as well as Catrix Ointment, creams and lip balm, in the treatment of a multiplicity of topical wounds. Additionally, the Company has pursued a program to establish the clinical efficacy of its POLY-NAG material as an anti-arthritic. The product is derived from specially processed crustacean shells (Poly-N-Acetyl-Glucosamine).
More from Market Guide: Expanded Business Description

Financial Summary
LCAR is engaged in research, testing, and development of medications for the control and cure of various diseases and the licencing of its technologies by other companies. LCAR has discovered and is primarily investigating Catrix(R). For the fiscal year ended 5/31/01, revenues fell 91% to $41 thousand. Net loss fell 6% to $568 thousand. Revenues reflect the absence of license fees earned. Lower loss reflects a decrease in cost of sales.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Gerard Dupuis, 62
Pres, CEO, Chairman, Gen. Counsel and Sec..
$150K
Charles Maxwell, 68
Director and Exec. VP
--  
William Sherman, Ph.D., 58
Exec. VP for Science Elect of the Company
--  
Dollar amounts are as of 31-May-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:LCAR.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 31-Aug-2001
$0.07 
Recent Price$0.07 
52-Week High
on 27-Nov-2000
$0.516
Beta1.27 
Daily Volume (3-month avg)6,545 
Daily Volume (10-day avg)3,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-82.8%
52-Week Change
relative to S&P500
-76.9%
Share-Related Items
Market Capitalization$1.57M
Shares Outstanding22.4M
Float10.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.02 
Earnings (ttm)-$0.03 
Earnings (mrq)-$0.01 
Sales (ttm)$0.00 
Cash (mrq)$0.00 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)38.22 
Income Statements
Sales (ttm)$41.0K
EBITDA (ttm)-$542.0K
Income available to common (ttm)-$570.0K
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsMay 31
Most recent quarter31-May-2001
Management Effectiveness
Return on Assets (ttm)-300.95%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.27 
Debt/EquityN/A 
Total Cash (mrq)$79.0K
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-May-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.